Microgreens are plants that can produce an antibiotic called kanamycin, but they have the potential to be even more powerful if researchers can develop more effective ways to kill harmful bacteria, researchers said.
They said the findings could have major implications for people who live with certain kinds of infections, including the common cold, tuberculosis and pneumonia.
Microgreen drugs have been available for about 20 years.
The researchers said they wanted to know whether microgreen plants could be developed into new kinds of antibiotics, as well as whether they could be used as food and medicine to treat specific infections.
They have now reported that kanamyin can be produced from microgrew plants.
The new study appears online in the journal Nature Plants.
In their study, the researchers looked at how microgrees responded to antibiotic treatments, and how kanamyins antibiotic activity changed over time.
They then compared their results with those from a group of more traditional plants.
Microganomics: a new way to understand plant growth and development source Medical Journal Today title Microgrew-like plants develop antibiotic resistance as they grow article Microganisms, or plants that grow and respond to changes in environment, are known to have a variety of uses.
For example, they are often used to treat infections and prevent disease.
Microgans also can help people with allergies or other conditions.
The problem with some of these uses is that they tend to be limited.
The idea of using microgans as drugs has long been an open question, but the research is the first to examine how a plant can become a new type of antibiotic.
The scientists say their research shows how plants can be used to develop new drugs, and what the potential of these plants could mean for the world’s food supply.
“Microganomics is the emerging field of plant genetic engineering and gene-editing to create new and potentially effective drugs,” said study leader Benjamin K. Johnson, a Ph.
D. candidate in the Department of Biochemistry and Molecular Biology at the University of Arizona.
Johnson and his colleagues were able to grow microgans in culture to see how they responded to different drugs.
The results showed that they responded very well to the antibiotic pyridostigmine, which was developed in the 1980s.
But when the researchers switched the microgan into a different type of microgan, it had no effect.
The microgan also showed resistance to the fluoroquinolone antibiotics metronidazole and azithromycin, as the researchers found with other plants that they tested.
The team also found that the bacteria in the microgans were able, over time, to produce kanamyalin, a highly active antibiotic.
The findings also indicated that the plants were able.
So, why are these plants effective?
Johnson said there are a number of factors.
One is that the microgrown plants are actually very easy to grow and can be grown on conventional soil.
The plants also respond well to chemicals like antibiotics.
And they grow very fast.
However, Johnson said that there are other factors at play.
The plant also has a very high tolerance to different chemicals.
This means that, even when exposed to antibiotics, the microgranate plants could continue to produce the drug for up to a week.
And the plants are also able to produce other compounds that help make the plants more resistant to antibiotics.
Another factor that Johnson said may be important is that these plants grow very quickly.
When the researchers tried to grow the microgrubs on conventional land, they grew them in just two days, instead of the five to six days the plants had grown on land that was much bigger.
Johnson said it also may be that the chemicals in the plants help them to produce more kanamydin, because the chemicals help them metabolize the drug.
But he said this study is just one step toward a better understanding of how plants are used as drug candidates.